PITOFSKY JASON (SVP Controller) sold 32.3% of their position (2.04K shares) of REGENERON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.59M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+1K
Price / share
$492.00
Trade value
$492K
% of position
Common Stock
Shares
−20.00
Price / share
$775.95
Trade value
$15.52K
% of position
Common Stock
Shares
−521.00
Price / share
$776.43
Trade value
$404.52K
% of position
Common Stock
Shares
−391.00
Price / share
$777.51
Trade value
$304.01K
% of position
Common Stock
Shares
−563.00
Price / share
$778.35
Trade value
$438.21K
% of position
Common Stock
Shares
−205.00
Price / share
$779.56
Trade value
$159.81K
% of position
Common Stock
Shares
−75.00
Price / share
$780.06
Trade value
$58.50K
% of position
Common Stock
Shares
−26.00
Price / share
$781.37
Trade value
$20.32K
% of position
Common Stock
Shares
−37.00
Price / share
$782.67
Trade value
$28.96K
% of position
Common Stock
Shares
−144.00
Price / share
$783.23
Trade value
$112.79K
% of position
Common Stock
Shares
−1.00
Price / share
$784.66
Trade value
$784.66
% of position
Common Stock
Shares
−53.00
Price / share
$785.72
Trade value
$41.64K
% of position
Net shares
−1.04K
Net value
-$1.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | M · Option Exercise | +1K | $492.00 | $492K | 18.8% | 5.31K | 6.31K |
| Common Stock Direct | 2/9/2026 | S · Sale | −20.00 | $775.95 | $15.52K | 0.3% | 6.31K | 6.29K |
| Common Stock Direct | 2/9/2026 | S · Sale | −521.00 | $776.43 | $404.52K | 8.3% | 6.29K | 5.77K |
| Common Stock Direct | 2/9/2026 | S · Sale | −391.00 | $777.51 | $304.01K | 6.8% | 5.77K | 5.38K |
| Common Stock Direct | 2/9/2026 | S · Sale | −563.00 | $778.35 | $438.21K | 10.5% | 5.38K | 4.81K |
| Common Stock Direct | 2/9/2026 | S · Sale | −205.00 | $779.56 | $159.81K | 4.3% | 4.81K | 4.61K |
| Common Stock Direct | 2/9/2026 | S · Sale | −75.00 | $780.06 | $58.50K | 1.6% | 4.61K | 4.53K |
| Common Stock Direct | 2/9/2026 | S · Sale | −26.00 | $781.37 | $20.32K | 0.6% | 4.53K | 4.51K |
| Common Stock Direct | 2/9/2026 | S · Sale | −37.00 | $782.67 | $28.96K | 0.8% | 4.51K | 4.47K |
| Common Stock Direct | 2/9/2026 | S · Sale | −144.00 | $783.23 | $112.79K | 3.2% | 4.47K | 4.33K |
| Common Stock Direct | 2/9/2026 | S · Sale | −1.00 | $784.66 | $784.66 | 0.0% | 4.33K | 4.33K |
| Common Stock Direct | 2/9/2026 | S · Sale | −53.00 | $785.72 | $41.64K | 1.2% | 4.33K | 4.27K |
| Total | −1.04K | -$1.09M | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
1K shares
Shares
−1K
Strike price
492.0
Held after
905.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1K shares | 2/9/2026 | M · Option Exercise | −1K | 492.0 | — | 905.00 |
Common Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 179.00 | Indirect |
| Common Stock | 31.00 | Indirect |
| Total | 210.00 | 210.00 indirect |